January 9: A manuscript from our collaborators entitled, “C60 Exposure Augments Cardiac Ischemia/Reperfusion Injury and Coronary Tone in Sprague-Dawley Rats” was accepted in Toxicological Sciences.
January 6: Our SOT symposium article entitled, “Symposium Overview: From Immunotoxicity to Nanotherapy: The Effects of Nanomaterials on the Immune System” was accepted in Toxicological Sciences.
December 30: Our manuscript entitled, “IL-33 Modulates Chronic Airway Resistance Changes Induced by Multi-Walled Carbon Nanotubes” was accepted in Inhalation Toxicology.
December 11: Our new Cytoviva enhanced darkfield hyperspectral imaging system was set-up in the lab.
November 25: Our invited opinions paper, “Engineered Nanomaterial Exposure and the Risk of Allergic Disease” was accepted in Current Opinions in Allergy and Clinical Immunology.
November 8: Jonathan won the Society of Toxicology Colgate Palmolive Fellowship Award in In Vitro Toxicology. The award is presented to one postdoctoral fellow each year and provides $44,000 for stipend and research costs. Jonathan will be presented the award at the 2014 SOT annual meeting in Phoenix, AZ.
September 19-20: The lab attended and presented oral and poster presentations at the Mountain West Society of Toxicology Annual Meeting in Albuquerque, NM. The theme of the meeting was Nanotoxicology. Jonathan won the best postdoctoral presentation award and was selected to be the postdoctoral representative for the regional chapter.
August 1: Our proteomics paper on silver nanoparticle-protein corona was accepted in PLOS ONE.
July 8: Wei Bai joined the Nanotoxicology Lab as a postdoctoral fellow.
July 1: Our SOT symposium proposal was accepted for the 2014 meeting in Phoenix. It is entitled, “Three dimensions of nanomaterial pulmonary toxicity: Innate immunity, TLRs and inflammasomes”. Drs. Sri Nadadur and Jared Brown are chairing the session and our invited speakers include Drs. Andrij Holian, Jamie Bonner, Tara Sabo-Attwood and Alex Star.
July 1: We relocated the Nanotoxicology Lab from the Brody School of Medicine at East Carolina University to the Skaggs School of Pharmacy, Departmental of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus.
Both Jonathan Shannahan and Abdul Aldossari relocated to Colorado to continue their fellowship and graduate studies respectively.